MV4
SGXStrides Pharma Science Ltd
Health CareIndia
Financial Summary
| Metric | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|
| Revenue | $3.4B | $3.2B | $3.6B | $4.5B |
| EBITDA | - | - | - | - |
| Net Profit | $2.7M | $20.9M | $24.8M | $42.2M |
| EPS | - | - | - | - |
| DPS | - | - | - | - |
Balance Sheet
Total Assets$2.0B
Total Liabilities-
Equity$1.2B
Net Debt$654.4M
Cash$156.1M
NTA/Share-
FY14
Price Chart
Insufficient price data
Key Metrics
P/E Ratio6.40
P/B Ratio0.41
EV/EBITDA9.38
Dividend Yield2.5%
ROE5.3%
ROA2.8%
Net Margin0.9%
Debt/Equity0.91
Net Debt/EBITDA5.45
FCF Yield-
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.